PCCs for PharmDs
Pharmacy to Dose: The Critical Care Podcast
00:00
Dosing Maintenance Infusions
We've used it, i think, on two or three patients since it's been approved. Compounding it in a timely fashion can be very challenging. We want to avoid overdosing as we might increase the risk of frambo and balk events. So if you're overdosing some on, you're wasting more money. And then we want to make sure we're not underdosing some ud. N our my heal system, it has it on formulary. There are strict restrition criteria limiting it to just inter cranial hemorrhages. M, they had to have their last dose within 18 hours,. kind of similar to the approval study.
Transcript
Play full episode
